NovartisNOVN 
$116.240.41%24h
0.41%24h
Global rank43
Market cap$238.92B
Change 7d-2.78%
YTD Performance13.78%
SP500 benchmarkUnderperform
P/E0
P/S5.12
Revenue$46.66B
Earnings$14.85B
Dividend yield3.0%
Main Sector
Healthcare
Market capitalization of Novartis (NOVN)
As of November 2024, Novartis has a market cap of $238.92B. This makes Novartis the world's 43th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Novartis from 1995 to 2024
-
Value:-
Market cap history of Novartis from 1995 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $213.48B | 3.64% |
| 2023 | $205.98B | 1.53% |
| 2022 | $202.88B | 4.12% |
| 2021 | $194.84B | -4.03% |
| 2020 | $203.02B | -8.98% |
| 2019 | $223.04B | 23.70% |
| 2018 | $180.31B | 1.99% |
| 2017 | $176.79B | 11.20% |
| 2016 | $158.98B | -14.63% |
| 2015 | $186.23B | -6.01% |
| 2014 | $198.14B | 29.71% |
| 2013 | $152.76B | 23.93% |
| 2012 | $123.26B | 6.98% |
| 2011 | $115.21B | -2.27% |
| 2010 | $117.89B | -3.43% |
| 2009 | $122.08B | 7.97% |
| 2008 | $113.07B | -15.14% |
| 2007 | $133.23B | -11.60% |
| 2006 | $150.72B | 1.74% |
| 2005 | $148.15B | 20.51% |
| 2004 | $122.93B | 2.05% |
| 2003 | $120.47B | 11.30% |
| 2002 | $108.24B | -15.92% |
| 2001 | $128.73B | -16.23% |
| 2000 | $153.67B | 8.32% |
| 1999 | $141.86B | -13.41% |
| 1998 | $163.83B | 13.92% |
| 1997 | $143.80B | 61.80% |
| 1996 | $88.88B | 52.54% |
| 1995 | $58.27B | - |
NOVN Market Cap Today is $238.92B 0.41% - 5 Nov 2024
View largest stocks by market cap 
